Search

Ali I Fattom

from Plymouth, MI
Age ~71
Get Report
Also known as:
Ali Dr Fattom, Ali L Fattom, Ali E Fattom, Ali Fatton
Phone and address:
51043 Plymouth Ridge Dr, Plymouth, MI 48170
(734) 667-5772
Related to:
Donald L O'Brien, 89Lina A Fattom, 45Iyad A Fattom, 40Dina Fattom, 42Shams M Fattom, 69
Connected to:
Charles J Fattome, 85Elizabeth A Fattor, 41Albert Fattore, 112Grady E Fattore, 58Heather M Fattore, 52Janet B Fattore, 70Alherta R Fattori, 96Brielle L Fattori, 28Mario V Fattori, 99Victoria Fattorini, 55

Ali Fattom Phones & Addresses

  • 51043 Plymouth Ridge Dr, Plymouth, MI 48170 (734) 667-5772
  • Ann Arbor, MI
  • 1710 Lorre Ct, Rockville, MD 20852 (301) 770-3937 (301) 770-4346
  • New York, NY
  • Clinton Township, MI
  • 1710 Lorre Dr, Rockville, MD 20852 (202) 550-7299

Work

Position: Professional/Technical

Education

Degree: Graduate or professional degree

Emails

d***[email protected]

Resumes

Resumes

Ali Fattom Photo 1

Senior Vice President Of Vaccines R And D, Bluewillow Biologics And Adjunct Research Associate Professor

View page
Location:
1710 Lorre Dr, Rockville, MD 20852
Industry:
Biotechnology
Work:
University of Michigan
Senior Vice President of Vaccines R and D, Bluewillow Biologics and Adjunct Research Associate Professor
Nanobio Corporation Currently Bluewillow Biologics
Senior Vice President of Vaccine Research and Development
Bluewillow Biologics and University of Michigan
Senior Vice President of Vaccines R and D and Associate Professor
Bluewillow Biologics, Inc.
Senior Vice President of Vaccine R and D + Adjunct Professor at U of M
Nabi Biopharmaceuticals 1991 - 2010
Vice President of Vaccine Research and Development
Education:
The Hebrew University of Jerusalem 1972 - 1983
Doctorates, Doctor of Philosophy, Ecology The Hebrew University of Jerusalem 1979 - 1983
Doctorates, Doctor of Philosophy, Microbiology Birzeit University
The Hebrew University of Jerusalem
Tel Aviv University
Masters, Master of Arts, Microbiology
Skills:
Vaccines
Infectious Diseases
Lifesciences
Microbiology
Biopharmaceuticals
Biotechnology
Cell Biology
Technology Transfer
Clinical Trials
Science
Molecular Biology
Research
Immunology
Biochemistry
Pharmaceutical Industry
Clinical Research
Cell Culture
Drug Discovery
Clinical Development
Protein Chemistry
Drug Development
Protein Purification
Cell
In Vitro
Immunohistochemistry
Cancer
Patents
Languages:
Arabic
English
Hebrew
Ali Fattom Photo 2

Adjunct Research Associate Professor At University Of Michigan

View page
Position:
Sr VP of Vaccine Research and Development at NanoBio Corporation, Adjunct Research Associate Professor at University of Michigan
Location:
United States
Industry:
Biotechnology
Work:
NanoBio Corporation since Nov 2010
Sr VP of Vaccine Research and Development
University of Michigan - Ann Arbor since Mar 2009
Adjunct Research Associate Professor
Nabi Biopharmaceuticals Jan 1991 - Nov 2010
Vice President of Research and Early Development
Nabi biopharmaceuticals 1991 - 2010
Vp of research
Bir-Zeit University - Birzeit, West Bank, Palestine 1981 - 1986
Assistant Professor, Microboiology
Education:
The Hebrew University 1972 - 1983
PhD, Microbial Ecology
Skills:
Infectious Diseases
Biotechnology
Vaccines
Molecular Biology
Lifesciences
Microbiology
Clinical Trials
Ali Fattom Photo 3

Ali Fattom

View page
Location:
United States

Publications

Us Patents

Compositions Of -Glucans And Specific Igiv

View page
US Patent:
6355625, Mar 12, 2002
Filed:
Sep 14, 1999
Appl. No.:
09/395360
Inventors:
Viliam Pavliak - Pittsford NY
Ali Ibrahim Fattom - Rockville MD
Robert B. Naso - Gaithersburg MD
Assignee:
Nabi - Rockville MD
International Classification:
A61K 31715
US Classification:
514 54, 514 75, 4241301, 4241651, 4241691
Abstract:
Compositions and kits comprising combinations of -glucans and specific immunoglobulins are disclosed. The compositions and kits are useful in methods of preventing or treating infection by a pathogenic microorganism, in which -glucan is administered to a subject, and specific antibodies to a pathogenic microorganism are introduced into the subject.

Hapten-Carrier Conjugates For Treating And Preventing Nicotine Addiction

View page
US Patent:
6518031, Feb 11, 2003
Filed:
Feb 16, 2001
Appl. No.:
09/784139
Inventors:
Sofiane Ennifar - Silver Spring MD
Ali Ibrahim Fattom - Rockville MD
Robert B. Naso - Gaithersburg MD
Assignee:
NABI - Rockville MD
International Classification:
G01N 3353
US Classification:
435 71, 5303889, 5303897, 5303898, 4241751, 4241931
Abstract:
Novel hapten-carrier conjugates are capable of inducing the production of antibodies, in vivo, that specifically bind to nicotine. These conjugates comprise a nicotine hapten conjugated to an immunogenic carrier protein. The novel conjugates preserve the chirality of nicotine in its native (S)-(-) state, and have good stability properties. The conjugates are useful in formulating vaccines for active immunization, that are used to prevent and treat nicotine addiction. The antibodies raised in response to the nicotine hapten-carrier conjugate are used for passive immunization. These antibodies are administered for prevention and treatment of nicotine addiction.

Staphylococcus Aureus Antigen-Containing Whole Cell Vaccine

View page
US Patent:
6537559, Mar 25, 2003
Filed:
Sep 24, 2001
Appl. No.:
09/961110
Inventors:
Ali Ibrahim Fattom - Rockville MD
Assignee:
NABI - Rockville MD
International Classification:
A61K 39085
US Classification:
4242431, 4241371, 4241651
Abstract:
A negatively-charged antigen contains -hexosamine as a major carbohydrate component. strains that carry the antigen account for nearly all of the clinically significant strains of that are not Type 5 or Type 8 strains. The antigen can be used in combination with Type 5 polysaccharide antigen and Type 8 polysaccharide antigen to provide nearly 100% coverage of infection. The antigen and antibodies to the antigen are useful in kits and assays for diagnosing infection. A whole cell vaccine of cells that contain the antigen is particularly useful in the treatment of mastitis.

Enterococcus Antigens And Vaccines

View page
US Patent:
6756361, Jun 29, 2004
Filed:
Oct 14, 1997
Appl. No.:
08/949757
Inventors:
Ali Ibrahim Fattom - Rockville MD
Ramesh K. Sood - Rockville MD
Sara E. Shepherd - Gaithersburg MD
Assignee:
NABI - Rockville MD
International Classification:
A01N 4304
US Classification:
514 54, 514 53, 514 25, 514885, 514904, 514 8, 435 734, 435 7021, 4241401, 42419711, 4242441, 2041828, 204452, 204450, 5303919
Abstract:
A majority of and clinical isolates fall into two groups and three groups, respectively. Distinct antigens are associate with each of the five groups. The Enterococcus antigens are readily obtained from strains of and , and can elicit production of protective antibodies. Accordingly, the antigens are useful for vaccines which protect against infection by clinically significant (pathogenic) Enterococcus isolates. The antigens and antibodies generated to the antigens are also useful in diagnostic assays.

Hapten-Carrier Conjugates For Treating And Preventing Nicotine Addiction

View page
US Patent:
6773891, Aug 10, 2004
Filed:
Dec 30, 2002
Appl. No.:
10/330676
Inventors:
Sofiane Ennifar - Silver Spring MD
Ali Ibrahim Fattom - Rockville MD
Robert B. Naso - Gaithersburg MD
Assignee:
NABI BioPharmaceuticals, Inc. - Rockville MD
International Classification:
G01N 3353
US Classification:
435 71, 435975
Abstract:
Novel hapten-carrier conjugates are capable of inducing the production of antibodies, in vivo, that specifically bind to nicotine. These conjugates comprise a nicotine hapten conjugated to an immunogenic carrier protein. The novel conjugates preserve the chirality of nicotine in its native (S)-(-) state, and have good stability properties. The conjugates are useful in formulating vaccines for active immunization, that are used to prevent and treat nicotine addiction. The antibodies raised in response to the nicotine hapten-carrier conjugate are used for passive immunization. These antibodies are administered for prevention and treatment of nicotine addiction.

Staphylococcus Antigen And Vaccine

View page
US Patent:
6936258, Aug 30, 2005
Filed:
Mar 19, 1999
Appl. No.:
09/272359
Inventors:
Viliam Pavliak - Potomac MD, US
Ali Ibrahim Fattom - Rockville MD, US
Assignee:
NABI Biopharmaceuticals - Boca Raton FL
International Classification:
A61K039/085
A61K039/02
A61K038/00
G01N033/569
C07K014/00
US Classification:
4242431, 4242781, 4242341, 4241841, 4242371, 4242351, 42419711, 530300, 530350, 530866, 5303871, 435 693, 435 733, 514 2
Abstract:
A negatively-charged antigen contains amino acids and a N-acetylated hexosamine as a major carbohydrate component. The antigen is common to many coagulase-negative strains of , including , and strains that carry the antigen include many clinically significant strains of. The antigen and antibodies to the antigen are useful in kits and assays for diagnosing infection. Vaccines of the antigen and of whole cells that carry the antigen also are disclosed.

Compositions Of Β-Glucans And Specific Antibodies

View page
US Patent:
7030101, Apr 18, 2006
Filed:
Feb 22, 2002
Appl. No.:
10/079537
Inventors:
Viliam Pavliak - Pittsford NY, US
Ali Ibrahim Fattom - Rockville MD, US
Robert B. Naso - Gaithersburg MD, US
Assignee:
Nabi Biopharmaceuticals - Rockville MD
International Classification:
A61K 39/40
A61K 31/716
US Classification:
514 54, 514 75, 5361231, 536 231, 536 232, 536124, 536 237, 536 235, 536 236, 536 551, 536 243, 4241931, 4241301, 4241651, 4241691, 435209, 435 4, 435 15, 435 691, 435 732, 510392, 800284
Abstract:
Compositions and kits comprising combinations of β-glucans and specific immunoglobulins are disclosed. The compositions and kits are useful in methods of preventing or treating infection by a pathogenic microorganism, in which β-glucan is administered to a subject, and specific antibodies to a pathogenic microorganism are introduced into the subject.

Hapten-Carrier Conjugates For Treating And Preventing Nicotine Addiction

View page
US Patent:
7247502, Jul 24, 2007
Filed:
Aug 3, 2004
Appl. No.:
10/909841
Inventors:
Sofiane Ennifar - Silver Spring MD, US
Ali Ibrahim Fattom - Rockville MD, US
Robert B. Naso - Gaithersburg MD, US
Assignee:
Nabi Biopharmaceuticals - Boca Raton FL
International Classification:
G01N 33/531
C07D 401/04
G01N 33/532
G01N 33/53
C07K 1/10
US Classification:
436543, 436544, 436816, 435 71, 530405, 514343
Abstract:
Novel hapten-carrier conjugates are capable of inducing the production of antibodies, in vivo, that specifically bind to nicotine. These conjugates comprise a nicotine hapten conjugated to an immunogenic carrier protein. The novel conjugates preserve the chirality of nicotine in its native (S)-(−) state, and have good stability properties. The conjugates are useful in formulating vaccines for active immunization, that are used to prevent and treat nicotine addiction. The antibodies raised in response to the nicotine hapten-carrier conjugate are used for passive immunization. These antibodies are administered for prevention and treatment of nicotine addiction.
Control profile
Ali I Fattom from Plymouth, MI, age ~71 Get Report